Homologous recombination repair pathway alterations and their relationship to homologous recombination deficiency in advanced pancreatic cancer patients

被引：1
|
作者：
Patel, Hitendra
Barrett, Alex
Mauer, Elizabeth
Kato, Shumei
Leibowitz, Benjamin D.
Singhi, Aatur D.
Javle, Milind M.
Lowy, Andrew M.
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
[2] Tempus Labs, Chicago, IL USA
[3] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] UCSD, Moores Canc Ctr, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
609
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Evaluation of Homologous Recombination Deficiency in Ovarian Cancer
    Ratnaparkhi, Rubina
    Javellana, Melissa
    Jewell, Andrea
    Spoozak, Lori
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (02) : 237 - 260
  • [32] The landscape of homologous recombination deficiency in colorectal cancer
    Ahsan, M.
    Bar-Mashiah, A.
    Webster, E.
    Qazi, M.
    Levi, S.
    Perez, L.
    Brewer, J.
    Frey, M.
    Sharaf, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S170 - S170
  • [33] Homologous recombination deficiency testing in Vietnamese patients with ovarian cancer
    Tran, N. H.
    Nguyen, P.
    Nguyen, T. A.
    Tu, L.
    ANNALS OF ONCOLOGY, 2024, 35
  • [34] Assessment of Homologous Recombination Deficiency in Ovarian Cancer
    Garg, Vikas
    Oza, Amit M.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 2957 - 2960
  • [35] Immune profiling of advanced prostate cancer harboring homologous recombination deficiency
    Soleimani, Maryam
    Kung, Sonia
    Saxena, Neetu
    Fazli, Ladan
    Nappi, Lucia
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Targeting homologous recombination repair defects in cancer
    Evers, Bastiaan
    Helleday, Thomas
    Jonkers, Jos
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (08) : 372 - 380
  • [37] Olaparib in patients (pts) with previously treated, homologous recombination repair mutation (HRRm) or homologous recombination deficiency (HRD)-positive advanced cancer: Phase II LYNK-002 study
    Hyman, David
    Hendifar, Andrew
    Chung, Hyun Cheol
    Maio, Michele
    Leary, Alexandra
    Spanggaard, Iben
    Rhee, Joon
    Marton, Matt
    Chen, Menghui
    Krishnan, Suba
    Shapira, Ronnie
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations
    Shore, N.
    Oliver, L.
    Shui, I.
    Gayle, A.
    Wong, O. Y.
    Kim, J.
    Payne, S.
    Amin, S.
    Ghate, S.
    JOURNAL OF UROLOGY, 2021, 205 (04): : 977 - 986
  • [39] Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications
    Moretto, Roberto
    Elliott, Andrew
    Zhang, Jian
    Arai, Hiroyuki
    Germani, Marco Maria
    Conca, Veronica
    Xiu, Joanne
    Stafford, Phillip
    Oberley, Matthew
    Abraham, Jim
    Spetzler, David
    Rossini, Daniele
    Antoniotti, Carlotta
    Marshall, John
    Shields, Anthony
    Lopes, Gilberto
    Lonardi, Sara
    Pietrantonio, Filippo
    Tomasello, Gianluca
    Passardi, Alessandro
    Tamburini, Emiliano
    Santini, Daniele
    Aprile, Giuseppe
    Masi, Gianluca
    Falcone, Alfredo
    Lenz, Heinz-Josef
    Korn, Michael
    Cremolini, Chiara
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (02): : 271 - 279
  • [40] Synergistic Interactions: Targeted Radiopharmaceuticals and Homologous Recombination Repair Alterations in Prostate Cancer
    Sartor, Oliver
    EUROPEAN UROLOGY, 2019, 76 (02) : 177 - 178
12345